Skip to main content
. 2021 Jul 20;11:20451253211029490. doi: 10.1177/20451253211029490

Figure 1.

Figure 1.

Mean number of admissions 2 years pre and post initiation of ALAI and PP1M in the all patient and schizophrenia groups.

ALAI, aripiprazole long-acting injectable; PP1M, once-monthly paliperidone palmitate.